Results 141 to 150 of about 5,013 (195)

PCN164 TWO DIFFERENT DOSES OF PALONOSETRON (PAL) FOR PREVENTION OF CHEMOTHERAPY-INDUCED VOMITING (CIV) IN PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC (MOHE) TREATMENT: SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA)

, 2009
Tobias Engel, O Clark, Ludovica Paladini, E Faleiros, LG Clark, B Pegoretti   +5 more
openalex   +1 more source

Comment on "Comparison of efficacy and safety between palonosetron and ondansetron to prevent postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a systematic review and meta-analysis". [PDF]

J Minim Invasive Surg
Kang HY.
europepmc   +1 more source

Exploring antiemetic strategies in hematologic malignancies: a comprehensive literature review and evaluation of antiemetic efficacy in patients receiving high-dose chemotherapy prior to hematopoietic stem cell transplantation. [PDF]

Support Care Cancer
Jordan K, Jordan B, Burgt JV, Jahn F.
europepmc   +1 more source

A comparative study of prophylaxis of post operative nausea and vomiting (PONV) with intravenous ondasetron, granisetron and palonosetron in patients undergoing laparoscopic abdominal and gynaecological surgeries under general anaesthesia

, 2020
Neha Bharti, Rajeev Lochan Tiwari, Anshu SS Kotia   +2 more
openalex   +1 more source

Correction to: Comparative effectiveness of netupitant-palonosetron plus dexamethasone versus aprepitant-based regimens in mitigating chemotherapy-induced nausea and vomiting: a meta-analysis of randomized controlled trials. [PDF]

Oncologist
europepmc   +1 more source

Comparison of efficacy and safety between palonosetron and ondansetron to prevent postoperative nausea and vomiting in patients undergoing non-laparoscopic surgery: A systematic review and meta-analysis of randomised controlled trials. [PDF]

Indian J Anaesth
Lal B, Alagarsamy R, Kumar J, Rai AJ, Yadav V, Joshi R, Yunus M.   +6 more
europepmc   +1 more source

Clinical Study on Palonosetron Combined with GDP Regimen in Treatment of Elderly Patients with Relapsed Non-Hodgkin's Lymphoma

, 2013
YE Wei-de
openalex   +1 more source

NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK [PDF]

, 2017
H Cawston, F. Bourhis, Jennifer Eriksson, Pierfrancesco Ruffo, Paolo D’Agostino, Marco Turini, Lee S. Schwartzberg, Alistair McGuire   +7 more
openalex   +1 more source

Efficacy of intensive antiemetic therapy including olanzapine in multiple myeloma patients treated with high-dose melphalan with autologous stem cell transplantation. [PDF]

Support Care Cancer
Kato J, Uchida M, Ishikawa M, Tatsuta S, Yoshimi T, Ishida K, Hosoya O, Tsukada N, Ishida T, Shiko Y, Kawasaki Y, Yamazaki S, Ishii I.   +12 more
europepmc   +1 more source

Efficacy of single low-dose dexamethasone with NEPA for the 168 h prevention of highly or moderately emetogenic chemotherapy. [PDF]

Front Pharmacol
He Y, Lou F, Huang X, Zhang Y, Lin Q, Tan W, Chen Q, Ren X, Shi H, Xiao L.   +9 more
europepmc   +1 more source